-
-
-
-
-
-
-
Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $66 at BofA Securities
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $90 at H.C. Wainwright
-
-
-
-
-
-
-
Wolfe Research Downgrades Vera Therapeutics (VERA) to Peerperform
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $85 at H.C. Wainwright
-
-
-
-
-
-
-
Vera Therapeutics Inc. (VERA) Reports Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial
-
-
-
-
-
-
-
Vera Therapeutics Inc. (VERA) Reports Q4, Provides Business Update
-
416,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

